WallStSmart

Fold Holdings, Inc. Class A Common Stock (FLD)vsInteractive Brokers Group Inc (IBKR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Interactive Brokers Group Inc generates 84365% more annual revenue ($6.21B vs $7.35M). IBKR leads profitability with a 15.9% profit margin vs 3.9%. FLD trades at a lower P/E of 1.8x. IBKR earns a higher WallStSmart Score of 66/100 (B-).

FLD

Buy

63

out of 100

Grade: C+

Growth: 7.3Profit: 3.0Value: 8.3Quality: 5.0
Piotroski: 4/9

IBKR

Strong Buy

66

out of 100

Grade: B-

Growth: 9.3Profit: 7.5Value: 9.3Quality: 5.3
Piotroski: 2/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

FLDUndervalued (+94.7%)

Margin of Safety

+94.7%

Fair Value

$28.08

Current Price

$1.47

$26.61 discount

UndervaluedFair: $28.08Overvalued
IBKRUndervalued (+26.5%)

Margin of Safety

+26.5%

Fair Value

$103.90

Current Price

$68.68

$35.22 discount

UndervaluedFair: $103.90Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

FLD3 strengths · Avg: 10.0/10
P/E RatioValuation
1.8x10/10

Attractively priced relative to earnings

Price/BookValuation
0.7x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
41.2%10/10

Revenue surging 41.2% year-over-year

IBKR6 strengths · Avg: 9.0/10
Operating MarginProfitability
78.8%10/10

Strong operational efficiency at 78.8%

Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Market CapQuality
$115.34B9/10

Large-cap with strong market position

Return on EquityProfitability
23.5%9/10

Every $100 of equity generates 24 in profit

Revenue GrowthGrowth
15.2%8/10

15.2% revenue growth

EPS GrowthGrowth
30.3%8/10

Earnings expanding 30.3% YoY

Areas to Watch

FLD4 concerns · Avg: 2.8/10
Market CapQuality
$52.25M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
2.8%3/10

ROE of 2.8% — below average capital efficiency

Profit MarginProfitability
3.9%3/10

3.9% margin — thin

Free Cash FlowQuality
$-5.03M2/10

Negative free cash flow — burning cash

IBKR3 concerns · Avg: 3.7/10
PEG RatioValuation
2.324/10

Expensive relative to growth rate

P/E RatioValuation
30.6x4/10

Premium valuation, high expectations priced in

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : FLD

The strongest argument for FLD centers on P/E Ratio, Price/Book, Revenue Growth. Revenue growth of 41.2% demonstrates continued momentum.

Bull Case : IBKR

The strongest argument for IBKR centers on Operating Margin, Debt/Equity, Market Cap. Profitability is solid with margins at 15.9% and operating margin at 78.8%. Revenue growth of 15.2% demonstrates continued momentum.

Bear Case : FLD

The primary concerns for FLD are Market Cap, Return on Equity, Profit Margin. Thin 3.9% margins leave little buffer for downturns.

Bear Case : IBKR

The primary concerns for IBKR are PEG Ratio, P/E Ratio, Piotroski F-Score.

Key Dynamics to Monitor

FLD profiles as a hypergrowth stock while IBKR is a growth play — different risk/reward profiles.

IBKR carries more volatility with a beta of 1.25 — expect wider price swings.

FLD is growing revenue faster at 41.2% — sustainability is the question.

IBKR generates stronger free cash flow (1.6B), providing more financial flexibility.

Bottom Line

IBKR scores higher overall (66/100 vs 63/100), backed by strong 15.9% margins and 15.2% revenue growth. FLD offers better value entry with a 94.7% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Fold Holdings, Inc. Class A Common Stock

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Fold Holdings, Inc. (FLD) is a forward-thinking biotechnology company harnessing advanced research methodologies to pioneer innovative therapies aimed at treating severe genetic and rare diseases. With a robust product pipeline supported by proprietary technologies, Fold is committed to reshaping the drug development landscape. The firm actively engages in strategic partnerships that enhance its market access and growth prospects, positioning it as a significant player in the biotechnology sector. By maintaining a strong focus on scientific excellence and patient-centric solutions, Fold Holdings is well-equipped for sustainable growth and value creation in the dynamic healthcare market.

Visit Website →

Interactive Brokers Group Inc

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Interactive Brokers Group, Inc. is a global automated electronic broker. The company is headquartered in Greenwich, Connecticut.

Want to dig deeper into these stocks?